1800 867 1390In this short video, leading oncologist Associate Professor Sid Baxi talks about the emerging role...
CPD requirements
Fulfils 50 hrs for medical professionals in Australia
Study modes
100% online
Course fee
$1355 (was $1595)
Use code 15BF24
Special rates available
Study duration
103.5 hrs
Self-paced
 |
 |
 |
Prof Marco Falasca
Professor of Metabolism
Professor, Metabolism, School of Pharmacy and Biomedical Sciences, Curtin University, Australia
Professor Marco Falasca graduated in Pharmacy and then in Pharmaceutical Chemistry at the University of Camerino, Italy. His education further includes a Diploma of Specialisation in Applied Pharmacology at the University of Bari and a FORMEZ Research Award (PhD equivalent) at the Consorzio Mario Negri Sud, Italy. After three years at the New York University Medical Center, Department of Pharmacology (Head Prof Joseph Schlessinger), Prof Falasca took up a position as Head of the Unit of Physiopathology of Cell Signalling within the Consorzio Mario Negri Sud in 1998.
In 2001 he moved to London where he was appointed as Principal Research Fellow, Senior Lecturer within the Department of Medicine at the University College London. In 2007 he was appointed as Professor of Molecular Pharmacology at the Queen Mary University of London. He is currently Professor of Metabolism at Curtin University, Australia. He has published more than 100 papers in reputed journals and has been serving as an editorial board member for several international journals.
The focus of Prof Falasca’s research in the past 25 years has involved the investigation of signalling pathways regulating intracellular physiological and pathological processes. Prof Falasca’s current specific projects are dedicated to the investigation of the mechanisms involved in development and progression of pancreatic diseases.
Prof Jonathon Arnold
Professor of Cannabinoid Pharmacology
Deputy Academic Director of the Lambert Initiative for Cannabinoid Therapeutics at the University of Sydney, Australia.
Professor Jonathon Arnold is a world leader in the science of cannabis and the cannabinoids. He is Deputy Academic Director of the Lambert Initiative for Cannabinoid Therapeutics at the University of Sydney, Australia. This is a cross faculty research initiative that specialises in the discovery and development of cannabis-based medicines. In 2018 he was one of four scientists selected to advise the World Health Organisation (WHO) on their historical review of cannabis and the cannabinoids.
Prof Arnold has over 20 years’ experience in cannabinoid pharmacology and has published extensively on the molecular, cellular, neurobiological and behavioural actions of the phytocannabinoids, cannabidiol (CBD) and tetrahydrocannabinol (THC). Since 2016 he and his team have conducted epilepsy research to improve the understanding of the anticonvulsant properties of the phytocannabinoids. He recently published a high-profile paper which shed new light on the mode of action of CBD in the treatment of childhood epilepsy (Altmetric 75). This paper received the Epilepsia Brain Science Prize honouring the most significant advance in knowledge in the field of epilepsy in 2019.
A/Prof Vicki Kotsirilos
AM, MBBS, FACNEM, FASLM
Expert Reviewer
Awarded Honorary Fellowship of the RACGP
Adjunct Associate Professor, NICM Health Research Institute
Research Committee Member, NICM Health Research Institute
Associate Professor Vicki Kotsirilos AM is a respected general practitioner with over 30 years of clinical experience, integrating evidence-based holistic therapies such as acupuncture, nutritional and herbal medicine with mainstream healthcare.
A/Prof Kotsirilos keeps up to date with the research in these areas culminating in the development of the successful textbook A Guide to Evidence-Based Integrative and Complementary Medicine. She is also a regular writer for Medical Observer, publishing a monthly column on evidence-based Integrative Medicine and circulates research updates for Australian doctors.
A/Prof Kotsirilos holds adjunct associate professorial positions with NICM and La Trobe University's, Department of Dietetics and Human Nutrition, Faculty of Health Sciences, and formerly with Monash University. She was the founding Chair of the RACGP Integrative Medicine Working group, as well as the founder and Founding Past President of the Australasian Integrative Medicine Association (AIMA).
A/Prof Kotsirilos served as an active board member on AIMA for 20 years, forging positive relations with government and peak medical bodies such as the AMA and RACGP. She has served on many state and federal government committees, such as the Therapeutic Goods Administration, Complementary Medicine Evaluation Committee (eight years) and as the GP member on the Adverse Drug Reactions Advisory Committee (five years). In addition, A/Prof Kotsirilos served on the Victorian Council of the AMA and for several years worked closely with the Medical Panels, Victorian Workcover. She continues to work for regulatory federal government bodies such as AHPRA.
Dr Orit Holtzman
MBBS, PhD
Chief Medical Officer, Compass Lifestyle Clinics
Co-Founder & Vice President, ANZCCP
Co-Founder & Vice President, ANZCCP
Dr Orit Holtzman is the Chief Medical Officer of Compass Lifestyle Clinics, where she practises functional and cannabinoid medicine, and the Co-Founder and Vice President of the Australian and New Zealand College of Cannabinoid Practitioners (ANZCCP).
Dr Holtzman holds a Bachelor of Science in biology and psychology from the University of Tel Aviv, a PhD in neuroscience from the University of NSW, and an MBBS from the Sydney Medical School at the University of Sydney. She is also a Kresser Institute Trained Practitioner in functional and evolutionary medicine.
After working in the public hospital system, Dr Holtzman has begun exploring holistic health solutions and become passionate about utilising medicinal cannabis as a therapeutic agent. She began prescribing cannabis in 2019, when she joined Compass Lifestyle Clinics. Dr Holtzman has prescribed medicinal cannabis for hundreds of patients for various indications, and is an authorised prescriber for multiple conditions. She is also a sought-after medical educator, teaching doctors about medicinal cannabis and the endocannabinoid system.
Dr Holtzman lives in the beautiful Blue Mountains in NSW with her husband and three children.
Dr Holtzman holds a Bachelor of Science in biology and psychology from the University of Tel Aviv, a PhD in neuroscience from the University of NSW, and an MBBS from the Sydney Medical School at the University of Sydney. She is also a Kresser Institute Trained Practitioner in functional and evolutionary medicine.
After working in the public hospital system, Dr Holtzman has begun exploring holistic health solutions and become passionate about utilising medicinal cannabis as a therapeutic agent. She began prescribing cannabis in 2019, when she joined Compass Lifestyle Clinics. Dr Holtzman has prescribed medicinal cannabis for hundreds of patients for various indications, and is an authorised prescriber for multiple conditions. She is also a sought-after medical educator, teaching doctors about medicinal cannabis and the endocannabinoid system.
Dr Holtzman lives in the beautiful Blue Mountains in NSW with her husband and three children.
.png?width=143&height=143&name=Joe%20Kosterich%20(3).png)
Dr Joe Kosterich
MBBS
Lecturer, Curtin Medical School
Dr Joe Kosterich is a general practitioner, speaker, author, media presenter and health industry consultant. He writes for numerous medical and mainstream publications and is a regular on radio and television. He is often called to give opinions in medico legal cases, is clinical editor of a medical magazine, adjunct professor (teaching) at UWA and a lecturer at Curtin Medical School.
Dr Kosterich has a special interest in medicinal cannabis, men’s health, chronic disease and mental health. He has self-published two books and maintains a website and blog with health information and commentary. Through all this, Dr Kosterich continues to see patients as a GP each week.
Dr Kosterich has a special interest in medicinal cannabis, men’s health, chronic disease and mental health. He has self-published two books and maintains a website and blog with health information and commentary. Through all this, Dr Kosterich continues to see patients as a GP each week.
Dr John Teh
MBBS
Cannabinoid Clinician, Clinical Educator
Medical Director, PlantMed
Dr John Teh is the Medical Director of Plantmed Medical Cannabis Clinic, Australia. He has been working within the Medicinal Cannabis industry since the legalisation of cannabis for medicinal use in Australia in February 2016.
Dr Teh is actively involved in Cannabis Medicine education, training medical practitioners and allied health professionals in all areas of cannabinoid therapeutics. He is a medical advisor to various cannabis producers and suppliers within Australia, and consulted the Thailand government prior their introduction of their medicinal cannabis program in 2019.
Dr Teh has vast experience treating a variety of patients with Medical Cannabis and integrates nutrition and plant based medicines which support cannabinoid treatment in his practice. His wealth of knowledge makes him sought after in all areas of cannabis medicine and education.
Dr Teh is actively involved in Cannabis Medicine education, training medical practitioners and allied health professionals in all areas of cannabinoid therapeutics. He is a medical advisor to various cannabis producers and suppliers within Australia, and consulted the Thailand government prior their introduction of their medicinal cannabis program in 2019.
Dr Teh has vast experience treating a variety of patients with Medical Cannabis and integrates nutrition and plant based medicines which support cannabinoid treatment in his practice. His wealth of knowledge makes him sought after in all areas of cannabis medicine and education.
In this week's case discussion, submitted by Dr John O'Bryen, a 61-year-old lady presents with...
With the rising global prevalence of conditions like pre-diabetes and type 2 diabetes,...
